How to Cite
Abstract
Preliminary data are confirmed on the more rare prevalence of family history of diabetes mellitus (DM) in cancer patients, mainly females, suffering with diabetes in comparison with diabetics without cancer pathology. Familial diabetes does not worse additionally tumor characteristics against the same in patients with non-familial diabetes. More than that, familial diabetes in diabetics with breast cancer goes together with lesser size of tumor and demonstrates an inclination to the rarer distant metastases in breast and endometrial cancer patients. The signs of systemic DNA damage (evaluated, in particular, on the basis of 8-OH-dG serum levels) are pronounced in postmenopausal diabetic cancer patients with familial diabetes in lesser degree than in non-familial variant of DM. In toto, this allows consider family history of DM in patients with diabetes type 2 as a peculiar factor of tumor growth containment, which mechanisms and causes warrant further studies.References
Берштейн Л.М., Бояркина М.П., Тесленко С.Ю., Васильев Д.А. Частота семейного диабета у страдающих диабетом онкологических больных // Вопр. онкол. — 2011. — Т. 57(4). — С.443-447.
Берштейн Л.М., Васильев Д.А., Порошина ТЕ. и др. Гормонально-метаболические особенности постменопаузальных женщин с впервые выявленным сахарным диабетом: роль онкологического заболевания и наследственной предрасположенности к диабету // Вестник РАМН. — 2013. — N2. — С. 29-34.
Берштейн Л.М., Мерабишвили В.М., Семенова Н.В. и др. Популяционный анализ сочетания рака и сахарного диабета: частота и особенности // Вопр. онкол. — 2007. — Т. 53(3). — С.285-290.
Дедов И.И., Шестакова М.В. Сахарный диабет (руководство для врачей). — М., Универсум Пабли-шинг. — 2003. — 456с.
Добрецов Г.Е. Флуоресцентные зонды в исследовании клеток, мембран и липопротеинов. — М., Наука. — 1989. — 274 с.
Berstein L. Marcosomy, Obesity and Cancer. NY. — Nova Science Publishers. — 1997. — 195p.
Berstein LM. Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer // Cancer Lett. — 2005. — Vol. 224(2). — P. 203212.
Brauer P.M., McKeown-Eyssen G.E., Jazmaji V. et al. Familial aggregation of diabetes and hypertension in a case-control study of colorectal neoplasia // Amer. J Epidemiol. — 2002. — Vol. 156(8). — P702-713.
Christensen MM, Brasch-Andersen C, Green H. et al. The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c // Pharmacogenet Genomics. — 2011. — Vol. 21(12). — P837-850.
Currie C.J., Poole C.D., Evans M. et al. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes // J Clin Endocrinol Metab. — 2013. — Vol. 98(2). — P 668-677.
Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. Report of a WHO/IDF consultation. — Geneva, Switzerland. — 2008. — 50 p.
Giovannucci E., Harlan D.M., Archer M.C. et al. Diabetes and cancer: a consensus report // Diabetes Care. — 2010. — Vol.33. — P1674-1685.
Ginter E., Simko V. Type 2 diabetes mellitus, pandemic in 21st century // Adv Exp Med Biol. — 2012. — Vol. 771. — P. 42-50.
Groop L., Forsblom C., Lehtovirta M. et al. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects // Diabetes. — 1996. — Vol.45. — P1585-1593.
Hemminki K, Li X, Sundquist J, Sundquist K. Risk of cancer following hospitalization for type 2 diabetes // Oncologist. — 2010. — Vol. 15(6). — P 548-555.
Hemminki K, Li X, Sundquist J, Sundquist K. Obesity and familial obesity and risk of cancer // Eur J Cancer Prev. - 2011. — Vol. 20(5). — P438-443.
InterAct Consortium. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study // Diabetologia. - 2013. — Vol. 56. — P. 60-69.
Mannino G.C., Sesti G. Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data // Mol Diagn Ther. — 2012. — Vol. 16(5). — Р285-302.
Meigs J.B., Cupples L.A., Wilson P.W. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes. - 2000 Dec. — 49. — Р2201-2207.
Papazafiropoulou A., Sotiropoulos A. , Skliros E. et al. Familial history of diabetes and clinical characteristics in Greek subjects with type 2 diabetes // BMC Endocr Disord. — 2009. — Vol. 9. — P12-21.
Piperakis S.M., Petrakou E., Tsilimigaki S. et al. Biomonitoring with the comet assay of Greek greenhouse workers exposed to pesticides // Environ Mol Mutagen. — 2003. — Vol. 41(2). — P104-110
Stephansson O., Granath F., Ekbom A., Michels K.B. Risk of breast cancer among daughters of mothers with diabetes: a population-based cohort study // Breast Cancer Res. — 2010. — Vol.12(1). — Р. 14.
Toyoshima H, Hayashi S, Hashimoto S et al. Familial aggregation and covariation of diseases in a Japanese rural community: comparison of stomach cancer with other diseases // Ann Epidemiol. — 1997. — Vol. 7(7). — P 446-451
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...